Aker Christopher Ray

CIK 00017626111 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001762611

Recent Transactions

47 trades

Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−363,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−70,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−45,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−7,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−393,750→ 0 total
Disposition from Tender
Regulus Therapeutics Inc.
Common Stock
2025-06-25−60,796→ 83,125 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−83,125→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−2,500→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−21,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−48,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−33,500→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−750→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−487,500→ 0 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2025-01-30+487,500→ 487,500 total
Sale
Regulus Therapeutics Inc.
Common Stock
2025-01-14$1.26/sh−5,088→ 49,546 total
Sale
Regulus Therapeutics Inc.
Common Stock
2025-01-13$1.26/sh−38,547→ 54,634 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.30/sh+17,500→ 93,181 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.36/sh+66,625→ 75,681 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+363,000→ 363,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2024-01-18$1.19/sh−5,468→ 10,056 total
Award
Regulus Therapeutics Inc.
Common Stock
2024-01-12+11,250→ 15,524 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-01-12+70,000→ 70,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+393,750→ 393,750 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-01-11+30,000→ 30,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-01-11+45,000→ 45,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-05-09+70,000→ 70,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2022-01-12+480,000→ 480,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2021-05-17$0.89/sh−860→ 41,754 total
Sale
Regulus Therapeutics Inc.
Common Stock
2021-02-16$1.72/sh−828→ 42,614 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2021-02-04+180,000→ 180,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-11-16$0.52/sh−876→ 25,762 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-08-14$0.60/sh−872→ 26,638 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-05-15$0.63/sh−909→ 27,510 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-02-18$0.83/sh−888→ 28,419 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2020-01-22+210,000→ 210,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2020-01-02$0.97/sh−2,239→ 29,307 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-11-14$0.64/sh−833→ 31,546 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2019-10-10+335,000→ 335,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-10-01$0.68/sh−2,346→ 32,379 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-08-15$0.55/sh−899→ 34,725 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-07-01$1.31/sh−2,225→ 35,624 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-05-15$1.41/sh−6,950→ 59,309 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2019-05-14+7,500→ 7,500 total
Award
Regulus Therapeutics Inc.
Common Stock
2019-05-14+38,512→ 66,259 total
Sale
Regulus Therapeutics Inc.
Common Stock
2019-04-01$0.98/sh−2,710→ 6,287 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2019-02-05+25,000→ 25,000 total
Award
Regulus Therapeutics Inc.
Common Stock
2019-02-05+25,000→ 27,747 total

Companies

Regulus Therapeutics Inc.
Sr. VP & General Counsel

Recent Filings

Address

C/O REGULUS THERAPEUTICS INC. 4224 CAMPUS POINT CT., #210

SAN DIEGO, CA, 92121

View on SEC.gov